GAL and cancer: Each of the agents, di-Gal-pHLIP, di-Gal-Peg4-pHLIP and di-Gal-Peg12-pHLIP, bound anti-Gal antibody when they were positioned at the surfaces of cancer cells within tumor spheroids (Figure 2A).